| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 1,652 | $74.79 | $123,553.08 | -2.7% | +12.6% | +3.9% | |
| Mar 24, 2021 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 1,181 | $76.30 | $90,110.30 | -1.9% | +8.6% | +8.2% | |
| Mar 18, 2021 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 1,308 | $77.99 | $102,010.92 | -2.0% | +6.6% | +5.5% | |
| Mar 12, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 14,000 | $77.39 | $1,083,460.00 | -4.5% | +6.7% | -3.1% | |
| Mar 5, 2021 | Michael G Grey49 | Director | Sale+OE | 5,000 | $76.28 | $381,400.00 | -10.5% | - | - | |
| Feb 19, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 7,000 | $83.58 | $585,060.00 | -2.3% | - | - | |
| Feb 18, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 7,000 | $85.08 | $595,560.00 | -2.3% | - | - | |
| Feb 17, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 8,000 | $84.54 | $676,320.00 | -2.6% | - | - | |
| Feb 16, 2021 | V Bryan Lawlis53 | Director | Sale+OE | 7,500 | $87.41 | $655,575.00 | -28.5% | - | - | |
| Jan 29, 2021 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 16,667 | $82.79 | $1,379,860.81 | -5.3% | - | - |